Vivanza Biosciences appoints CS Vishal Sureshbhai Katarmal

0 min read     Updated on 09 Jul 2026, 04:15 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Vivanza Biosciences Limited appointed CS Vishal Sureshbhai Katarmal as Company Secretary and Compliance Officer effective July 9, 2026. The Board approved the appointment during a meeting held on the same day, pursuant to Section 203 of the Companies Act, 2013, and Regulation 6(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

powered bylight_fuzz_icon
45138769

*this image is generated using AI for illustrative purposes only.

Vivanza Biosciences Limited appointed CS Vishal Sureshbhai Katarmal as its Company Secretary and Compliance Officer effective July 9, 2026, to strengthen its regulatory compliance framework. The Board of Directors approved the appointment during a meeting held on July 9, 2026, pursuant to Section 203 of the Companies Act, 2013, and Regulation 6(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment Details

CS Vishal Sureshbhai Katarmal is an Associate Member of the Institute of Company Secretaries of India (ACS: 78544). He brings experience in dealing with matters of the Companies Act, Listing Regulations, and allied laws. The appointment follows the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Particulars Details
Appointee Name CS Vishal Sureshbhai Katarmal
Designation Company Secretary and Compliance Officer
Membership Number ACS: 78544
Effective Date July 9, 2026

Board Meeting Proceedings

The meeting of the Board of Directors commenced at 15:15 P.M. and concluded at 15:30 P.M. The disclosure was submitted to the stock exchange in compliance with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015.

Historical Stock Returns for Vivanza Biosciences

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-2.63%+8.82%-17.41%-12.32%-84.95%

What specific regulatory challenges is Vivanza Biosciences currently facing that prompted the strengthening of its compliance framework?

How will CS Katarmal's previous experience influence Vivanza Biosciences' approach to upcoming SEBI regulatory changes?

Are there additional senior management appointments planned to support the company's governance structure?

Vivanza Biosciences signs strategic cooperation agreement for Kyrgyz film project

1 min read     Updated on 29 Jun 2026, 03:29 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Vivanza Biosciences Limited has entered into a Strategic Cooperation, Investment & Technology Transfer Agreement with Mr. Kalybek Uulu Bekturgan for a Plastic Film Manufacturing Project in the Kyrgyz Republic. The non-binding agreement encompasses technology transfer, investment facilitation, and potential joint venture formation. No monetary consideration was paid initially, and the company expects the move to enhance its international presence and export markets.

powered bylight_fuzz_icon
44272747

*this image is generated using AI for illustrative purposes only.

Vivanza Biosciences Limited has signed a Strategic Cooperation, Investment & Technology Transfer Agreement with Mr. Kalybek Uulu Bekturgan to establish a Plastic Film Manufacturing Project in the Kyrgyz Republic. The international agreement aims to strengthen the company's presence in the region through industrial cooperation and technology transfer. No monetary consideration was exchanged at the signing of this non-binding pact.

The agreement outlines a scope of work that includes technology transfer, project design and implementation support, machinery sourcing, and government liaison. It also provides for investment facilitation, skill development, import-export promotion, and financing assistance. The parties may explore the possibility of establishing a Joint Venture Company, subject to the execution of definitive agreements and necessary approvals.

Key Agreement Details

Particulars Details
Name of Entity Vivanza Biosciences Limited and Mr. Kalybek Uulu Bekturgan
Area of Agreement Strategic cooperation for establishment of Plastic Film Manufacturing Project
Location Kyrgyz Republic
Consideration No monetary consideration at present
Related Party Transaction Not Applicable (N.A.)

The company expects the arrangement to facilitate international industrial cooperation and expand export markets. While the agreement is intended to create long-term growth opportunities, the company noted that no immediate financial benefit can be quantified due to the non-binding nature of the pact. Vivanza Biosciences will disclose any termination of the arrangement to the stock exchange in accordance with SEBI regulations.

Historical Stock Returns for Vivanza Biosciences

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-2.63%+8.82%-17.41%-12.32%-84.95%

What is the projected timeline for executing definitive agreements and establishing the Joint Venture Company?

How will Vivanza Biosciences secure the necessary financing for the project given no monetary consideration was exchanged upfront?

What specific regulatory approvals from the Kyrgyz Republic government are required before operations can commence?

More News on Vivanza Biosciences

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-12.32%